• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Avian Influenza Vaccine Companies

    ID: MRFR/Pharma/7297-CR
    101 Pages
    Rahul Gotadki
    February 2020

    Avian influenza, commonly known as bird flu, poses a significant threat to global poultry populations and has the potential for zoonotic transmission to humans. In response to this ongoing challenge, several pioneering companies have emerged as leaders in the development and production of avian influenza vaccines. These vaccines play a crucial role in preventing and controlling the spread of the virus among birds, safeguarding both animal welfare and human health.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Avian Influenza Vaccine Market Research Report - Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Avian Influenza Vaccine Market

    Avian Influenza Vaccine Key Companies

     


    Latest Avian Influenza Vaccine Companies Update:

    December 2023:


    The United States Department of Agriculture (USDA) announces a $10 million grant program to support research and development of advanced avian influenza vaccines for poultry. This initiative aims to create next-generation vaccines offering broader protection against diverse influenza strains.


    October 2023:


    Ceva Animal Health releases their CEVA FLU H5/H7 vaccine, a new recombinant adenovirus vector vaccine for poultry, providing broader coverage against various Influenza A subtypes.


    July 2023:


    A research team in China publishes a successful trial of a DNA vaccine for chickens, potentially paving the way for more stable and scalable vaccine production.


    January 2024:


    Moderna reports positive preliminary results from their Phase 1 trial for a mRNA-based avian influenza vaccine in humans. This signifies progress in creating human vaccines for potential future outbreaks.


    November 2023:


    The World Health Organization (WHO) updates its avian influenza preparedness plan, emphasizing the need for developing and stockpiling human vaccines alongside poultry vaccines.


    August 2023:


    Sanofi announces its readiness to start production of existing H5N1 vaccines if needed in an avian influenza outbreak scenario, highlighting the existing


    List of Avian Influenza Vaccine Key companies in the market

    • Boehringer Ingelheim International GmbH (Germany)

    • Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China)

    • Ceva (US)

    • Yebio Bioengineering Co., Ltd (China)

    • Zoetis (US)

    • FATRO S.P.A. (Italy)

    • CAVAC (South Korea)

    • Tianjin Ringpu Bio-Technology Co., Ltd (China)

    • PT Japfa Comfeed Indonesia Tbk (Indonesia)

    • Chengdu Tech-bank Biological Products Co., Ltd (China)

    • Merck Animal Health (US)

    • Medion (Indonesia)

    • Avimex Animal Health (Mexico)

    • JOVAC (Jordan)

    • QYH BIOTECH COMPANY LIMITED (China).